Message Font: Serif | Sans-Serif
No. of Recommendations: 0
hula - if you haven't read it already, the Motely Fool Investment guide has a great chapter on valuing stocks.

Stock prices reflect anticipated future earnings. When a stock is expected to earn a great deal, the price and P/E rise. Believe it or not, you can make a good argument that BONZ is a cheap stock, even with a P/E of 47.

The idea is that a fairly valued stock's P/E should roughly equal its growth rate, so the P/E divided by growth rate will equal 1. Currently, First Call's mean estimate for Bonz's long term growth rate is 83%. Obviously, 83% is a phenomenal growth rate which could justify a higher P/E. As you indicated the P/E is 47. Divide 83 by 47 and you get .57, placing BONZ in the undervalued range. If BONZ delivers on the growth, the price will rise much higher than a fairly valued stock and you will make a lot of money.

That being said, I am just starting to look at this company. From what I can tell, BONZ is a one product company (someone correct me if I am wrong), so that unlike a big diversified blue chip, if Pro-osteon for some reason gets outlawed by the FDA down the line (remember Phen-fen?) the stock will get killed. Also, if BONZ fails to deliver on the anticipated growth, the fall will be much harder than for a low P/E stock.

In other words, BONZ is not for the faint of heart.

Hope that helps.
Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.